The FDA granted Minneapolis-based NightWare a De Novo clearance on Friday for its Apple Watch and iPhone app designed to improve the sleep quality of those experiencing nightmare disorder and nightmares related to PTSD. [Read more…] about FDA grants clearance for NightWare app designed to reduce PTSD-related nightmares
Hoping you enjoy this slidedeck supporting a great discussion held during the 2019 SharpBrains Virtual Summit: The Future of Brain Health (March 7–9th). Full recordings are available for purchase here.
9–10.30am. How to detect problems early: Examples in Alzheimer’s Disease, Parkinson’s, anxiety and PTSD
- Dr. Srijan Sen, Professor of Depression and Neurosciences at University of Michigan
- Jan Samzelius, Co-Founder and Chief Scientist of NeuraMetrix
- Dr. Tony Chang, Associate at Merck Ventures
- Chaired by: Dr. Deanna Belsky, Associate at Dolby Family Ventures
Psychedelics in Neurology: Potential for Improving Neuroplasticity (NeurologyTimes):
“Back in the 1950s, research was proving that psychedelic agents could be effective in the treatment of various neuropsychiatric disorders. Unfortunately, just as science was exploring their beneficial effects, the counterculture was exploring and embracing their effects. Slowly but surely, psychedelics were associated with rebellious youth and the tumultuous anti-war movement. As a result, the government shut down most of the research.
The 1990s saw renewed interest in psychedelic compounds as a means to address neuropsychiatric disorders. Research explored the benefits of MDMA and ketamine to treat mood disorders and posttraumatic stress disorder. Now, a new study sheds even more light on the promise these agents might provide. [Read more…] about Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health
“In the era of college student sensitivities to a seemingly ever-increasing list of possible offending material, the use of so-called “trigger warnings” has become commonplace on university campuses. These warnings are usually given at the beginning of a class (or at the beginning of specific sections of a class) to prepare students…”
After controlling for various factors, such as sex, race, age, psychiatric history, and political orientation, the researchers found that those participants who received trigger warnings were significantly more likely (compared to those in the control condition) to suggest that they and others would be more vulnerable to emotional distress after experiencing trauma. [Read more…] about Study: Trigger warnings don’t work, may undermine emotional resilience
Dr. Serin, what surprised you the most from the Judges’ questions and feedback during the Brainnovations Pitch Contest?
It was great that at least one of the judges had already purchased and started using our product so we could delve into the nuances of our technology quickly. And I was thrilled that all judges saw the possibilities to create significant global impact.
In a nutshell, what is the core idea behind TouchPoints?
Too many people suffer too much stress, often leading to sleeplessness, cravings, anger, poor focus, poor performance, and feeling overwhelmed. TouchPoints aim at reducing stress by delivering haptic microvibrations via wearable devices worn on both sides of the body. The [Read more…] about Neuropsychologist Amy Serin, Co-Founder of Brainnovations Winner The Touchpoint Solution, would like to see everyone avoid the detrimental effects of an overactive stress response
Drugs for PTSD linked to increased risk of dementia (The Pharmaceutical Journal):
“Certain psychotropic drugs used to treat post-traumatic stress disorder (PTSD) increase the risk of developing dementia, including in patients who do not have PTSD but take the drugs for other conditions, study results published in the Journal of the American Geriatrics Society [Read more…] about Study: Common medication treatments for PTSD can increase the risk of developing dementia